×
Back to Agenda
Session # 2 FUTURISTIC PRECLINICAL DEVELOPMENT – TRENDS AND OPPORTUNITIES
Session Chair(s)
Kiran Marthak, MD, FFPM, FRCP
Director, Phase 1 & Regulatory, Lambda Therapeutic Research Ltd., India
Charu Gautam, MD
Senior Director- Medical Science and Strategy, IQVIA, India
Speaker(s)
Ramachandra Sangana
Senior Investigator, PK Sciences, Novartis, India
CENTRAL ROLE OF DMPK IN DRUG DESIGN AND DEVELOPMENT
Pramod Kabra, MD
Director, Healthcare- India and South Asia, Thermofisher, India
ROLE OF GENOMICS AND BIOMARKERS IN DRUG DISCOVERY AND DEVELOPMENT
Have an account?